Clinical Trial Update: Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating Theophylline, N-acetylcysteine, and their combination to prevent contrast-induced nephropathy, spanning Phase 2 and Phase 3, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• Theophylline (Theophylline)
• Theophylline plus N-acetylcysteine (Theophylline plus N-acetylcysteine)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Contrast-Induced Nephropathy | Phase 2, Phase 3 | Status: UNKNOWN